Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin F Gibson

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory Cell and Molecular Biology|July 17, 2014
A novel genomic signature with translational significance for human idiopathic pulmonary fibrosisYasmina Bauer, John Tedrow, Simon de Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patientsJianmin Xue, Daniel J Kass, Jessica Bon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cellular and humoral autoreactivity in idiopathic pulmonary fibrosisCarol A Feghali-Bostwick, Christopher G Tsai, Vincent G Valentine, et al.
The European Respiratory Journal|October 24, 2015
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumabGanesh Raghu, Fernando J Martinez, Kevin K Brown, et al.
Thorax|August 13, 2017
Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosisGeorgios D Kitsios, Mauricio Rojas, Daniel J Kass, et al.
Respirology (Carlton, Vic.)|April 4, 2018
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertensionArgyrios Tzouvelekis, Jose D Herazo-Maya, Changwan Ryu, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansGuoying Yu, Elisabetha Kovkarova-Naumovski, Paul Jara, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
The European Respiratory Journal|July 19, 2014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisMarc A Judson, Robert P Baughman, Ulrich Costabel, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory Cell and Molecular Biology|July 17, 2014
A novel genomic signature with translational significance for human idiopathic pulmonary fibrosisYasmina Bauer, John Tedrow, Simon de Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patientsJianmin Xue, Daniel J Kass, Jessica Bon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cellular and humoral autoreactivity in idiopathic pulmonary fibrosisCarol A Feghali-Bostwick, Christopher G Tsai, Vincent G Valentine, et al.
The European Respiratory Journal|October 24, 2015
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumabGanesh Raghu, Fernando J Martinez, Kevin K Brown, et al.
Thorax|August 13, 2017
Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosisGeorgios D Kitsios, Mauricio Rojas, Daniel J Kass, et al.
Respirology (Carlton, Vic.)|April 4, 2018
S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertensionArgyrios Tzouvelekis, Jose D Herazo-Maya, Changwan Ryu, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansGuoying Yu, Elisabetha Kovkarova-Naumovski, Paul Jara, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
The European Respiratory Journal|July 19, 2014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisMarc A Judson, Robert P Baughman, Ulrich Costabel, et al.
Pageof 8